Abstract: The present invention relates to a laundry composition for the removal of stains, which comprises at least one bleaching agent, at least one bleach activator, and a dye transfer inhibitor system comprising a copolymer of 1-vinyl-2-pyrrolidone and 1-vinylim-idazole, and a homopolymer of 1-vinyl-2-pyrrolidone: wherein the weight ratio between the copolymer of 1-vinyl-2-pyrrolidone and 1-vinylimidazole and the homopolymer of 1-vinyl-2-pyrrolidone is of between 1:1 to 5:1. It also relates to a method of washing a garment using the laundry composition and to the use of the laundry composition for the removal of stains from a garment and dye transfer reduction or inhibition from a garment.

Abstract: A primary structure (100) for a spacecraft (200) including an interface ring (10) and a predetermined number of panels defining a box arranged to close an interior volume of the spacecraft. The box is connected to the interface ring. Side panels of the box are parallel to a geometric axis (A) of the interface ring, the interface ring is temporarily fastened to a system supporting the spacecraft in a launcher. Each panel is a one-piece panel formed by machining a metal material. The side panels at the base of the box are connected to the interface ring (10) via damping inserts (60).

Abstract: A system for determining the prognosis of a patient suffering from pulmonary embolism is provided. The system may include at least one computer system configure to receive patient specific data regarding his pulmonary embolism status. The at least one computer system may be further configured to create a model of the patient's heart, with at least information of the two ventricles, and to determine the ratio of sizes of the ventricles. The system will then report such ratio to the clinician or report a risk index of clinical outcome for such patient.

Abstract: The present invention makes reference to new indene derivatives with general formula (I), as well as to their preparation procedures, their application as medicament and the pharmaceutical compositions containing them. The new compounds of formula (I) show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.

Abstract: The present invention refers to new indanyl sulphonamide compounds with general formula (I), as well as to their preparation procedure, their application as medicine and the pharmaceuticals composition which they are made up of. The new compounds of formula I show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.

Abstract: The present invention refers to new indanyl sulphonamide compounds with general formula (I), as well as to their preparation procedure, their application as medicine and the pharmaceuticals composition which they are made up of. The new compounds of formula (I) show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.

Abstract: The present invention makes reference to new indene derivatives with general formula (I), as well as to their preparation procedures, their application as medicament and the pharmaceutical compositions containing them. The new compounds of formula (I) show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.

Abstract: The present invention refers to new indanyl sulphonamide compounds with general formula (I), as well as to their preparation procedure, their application as medicine and the pharmaceuticals composition which they are made up of. The new compounds of formula I show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.